Rising prevalence of brain and spinal cord disorders coupled with demand for minimally invasive procedures for the treatment of these disorders are the key factors driving the global neuroendoscopy market. The neuroendoscopy is used to perform various procedures such as obstructions, ventriculostomies, biopsies and removal of tumors & cysts. According to American Brain Tumor Association, brain tumor is the major cause of cancer related deaths in children under the age of 20. It also states that around 700,000 people in the U.S. are suffering from brain tumor. Additinally, increasing incidence rate of life threatening colloid cysts are expected to lead the growth of the neuroendoscopy market over the forecast period. The rising demand for neuroendoscopy devices is a direct consequence of increasing incidences of chronic diseases such as cancer and brain diseases. In addition, rising awareness among people regarding the treatment of diseases related to brain and spinal cord is anticipated to propel the market growth over next seven years. However, existence of substitute treatment such as chemotherapy, gamma knife surgeries and radiation therapy isexpected to be a growth impeding factor for this market in near future.
The overall neuroendoscopic market is segmented on the basis of product type into rigid endoscopes, endoscopic visualization systems, flexible endoscopes, endoscopic ultrasound (eus), endoscope fluid management systems and endoscope accessories. As of 2014, the rigid endoscope segment contributed largest share in the market owing to its efficiency and high success rate for removal of brain tumors. However, price intensive nature of these devices and inadequate reimbursement policies in various countries are expected to restrain the market growth for rigid endoscopes.
Geographically, the entire neuroendoscopic market is categorized into North America, Asia Pacific, Europe, Latin America and MEA. As of 2014, North America contributed largest revenue share followed by Europe. This dominance is due to the rising cases of brain tumors and increasing adoption of minimally invasive procedures by hospitals as a cost containment measures in this region. Asia Pacifc is expected to witness lucrative growth over next seven years due to huge untapped opportunities, rising disposable income level and rapidly improvising healthcare infrastructure are other key growth drivers of neuroendoscopic market in this region.
The global neuroendoscopic market is competitive in nature and consists few companies contributing more than two third of the market. Key players operating in the neuroendoscopic market include Adeor, Karl Storz and Aesculap. Other notable companies in the market are Covidien, Richard Wolf, ConMed and Medtronic. Some neuroendoscopic devices manfactures in an attempt to gain market share have adopted collaborative strategy with imaging and optical expert companies in Asia Pacific region such as Olympus, Fuji and Sony etc. thereby, propelling overall growth of neauroendoscopy market in near future.
Avail customized purchase options to meet your exact research needs:
Get your queries resolved from an industry expert.
Design an exclusive study to serve your research needs.
A testimonial for service in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.
"The quality of research they have done for us has been excellent..."